General Information of the Compound
Compound ID
CP0351155
Compound Name
4-[[4-fluoro-3-(4-methoxypiperidine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one
    Show/Hide
Synonyms
1(2H)-Phthalazinone, 4-((4-fluoro-3-((4-methoxy-1-piperidinyl)carbonyl)phenyl)methyl)-
1(2H)-Phthalazinone, 4-[[4-fluoro-3-[(4-methoxy-1-piperidinyl)carbonyl]phenyl]methyl]-
1174043-16-3
3K288XF5XJ
4-(4-Fluoro-3-((4-methoxypiperidin-1-yl)carbonyl)benzyl)phthalazin-1(2H)-one
4-(4-fluoro-3-(4-methoxypiperidine-1-carbonyl)benzyl)phthalazin-1(2H)-one
4-[4-Fluoro-3-[(4-methoxypiperidin-1-yl)carbonyl]benzyl]phthalazin-1(2H)-one
AZD 2461
AZD-2461
AZD2461
HYNBNUYQTQIHJK-UHFFFAOYSA-N
SCHEMBL77012
UNII-3K288XF5XJ
    Show/Hide
Structure
Formula
C22H22FN3O3
Molecular Weight
395.434
Canonical SMILES
COC1CCN(CC1)C(=O)c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F
    Show/Hide
InChI
InChI=1S/C22H22FN3O3/c1-29-15-8-10-26(11-9-15)22(28)18-12-14(6-7-19(18)23)13-20-16-4-2-3-5-17(16)21(27)25-24-20/h2-7,12,15H,8-11,13H2,1H3,(H,25,27)
    Show/Hide
InChIKey
HYNBNUYQTQIHJK-UHFFFAOYSA-N
CAS
1174043-16-3
Physicochemical Property
logP
2.904
Rotatable Bonds
4
Heavy Atom Count
29
Polar Areas
75.29
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44199317
SID: 85195302
ChEMBL ID
CHEMBL4098253
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00839, Poly [ADP-ribose] polymerase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000623 OVCAR-8 Homo sapiens (Human)  1
1
IC50 = 1.7 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( AZD-2461 )
Drug Name AZD-2461
Company AstraZeneca
Indication
Solid tumour/cancer
Phase 1